ClinVar Miner

Submissions for variant NM_000321.3(RB1):c.411A>T (p.Glu137Asp)

gnomAD frequency: 0.00040  dbSNP: rs3092902
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 12
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Labcorp Genetics (formerly Invitae), Labcorp RCV000989108 SCV000284626 benign Retinoblastoma 2024-02-01 criteria provided, single submitter clinical testing
Ambry Genetics RCV000570544 SCV000664578 likely benign Hereditary cancer-predisposing syndrome 2018-08-27 criteria provided, single submitter clinical testing This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity.
Mendelics RCV000034596 SCV001139307 benign not provided 2022-12-13 criteria provided, single submitter clinical testing
Illumina Laboratory Services, Illumina RCV000989108 SCV001271623 benign Retinoblastoma 2018-10-09 criteria provided, single submitter clinical testing This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. The evidence from the literature, in combination with allele frequency data from public databases where available, was sufficient to rule this variant out of causing disease. Therefore, this variant is classified as benign.
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories RCV000034596 SCV001472180 likely benign not provided 2020-04-07 criteria provided, single submitter clinical testing
GeneDx RCV000034596 SCV001772964 likely benign not provided 2021-03-22 criteria provided, single submitter clinical testing This variant is associated with the following publications: (PMID: 27153395, 15776430, 9311732, 15884040, 26933808, 25742471, 23810757, 27600092, 16546179, 20596833, 7981694, 7795591, 22703879, 17996702, 8364580)
Sema4, Sema4 RCV000570544 SCV002530849 likely benign Hereditary cancer-predisposing syndrome 2020-10-21 criteria provided, single submitter curation
Color Diagnostics, LLC DBA Color Health RCV000989108 SCV004357194 benign Retinoblastoma 2022-04-26 criteria provided, single submitter clinical testing
PreventionGenetics, part of Exact Sciences RCV003952395 SCV004776324 likely benign RB1-related disorder 2021-11-16 criteria provided, single submitter clinical testing This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications).
Genetic Diagnostic Laboratory, University of Pennsylvania School of Medicine RCV000989108 SCV005046378 likely benign Retinoblastoma 2024-05-20 criteria provided, single submitter clinical testing Case and Pedigree Information: BILATERAL CASES:0, UNILATERAL CASES:1, TOTAL CASES:1, PEDIGREES:1. ACMG Codes Applied:BS1, BP6
CeGaT Center for Human Genetics Tuebingen RCV000034596 SCV005093258 likely benign not provided 2024-07-01 criteria provided, single submitter clinical testing RB1: BP4
Biesecker Lab/Clinical Genomics Section, National Institutes of Health RCV000034596 SCV000043463 variant of unknown significance not provided 2012-07-13 no assertion criteria provided research Converted during submission to Uncertain significance.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.